Prasco LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Prasco LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7535
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Prasco LLC (Prasco Laboratories) is a pharmaceutical company that manufactures and markets authorized generic and generic products. The company’s authorized generic products include acitretin capsules, clotrimazole and betamethasone dipropionate cream, atovaquone and proguanil HCl tablets, calcipotriene cream, and carbamazepine extended-release capsules. It also provides augmented betamethasone dipropionate, levalbuterol HCl inhalation solution, mirtazapine orally disintegrating tablets and mupirocin calcium cream, among others. Prasco Laboratories’ generic products comprise duloxetine delayed release capsules, olanzapine orally disintegrating tablets, raloxifene Hcl, pantoprazole sodium delayed-release tablets, and olanzapine tablets. The company partners with various pharmaceutical companies for manufacturing authorized generic products. It has operations in Cincinnati and Washington D.C., the US. Prasco Laboratories is headquartered in Mason, Ohio, the US.

Prasco LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Prasco LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Prasco LLC, Medical Devices Deals, 2012 to YTD 2018 9
Prasco LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Prasco LLC, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Prasco to Acquire Authorized Generic of Adderall XR Capsules from Teva Pharma and Shire 11
Partnerships 13
Prasco Lab Enters into Co-Marketing Agreement with Takeda Pharma 13
Prasco Labs Enters into Distribution Agreement with Recordati Rare Diseases 14
Prasco Labs Enters Into Distribution Agreement With Eli Lilly For Evista 15
Prasco Labs Enters Into Agreement With Shire For Distribution Of Fosrenol 16
Prasco Labs Enters Into Distribution Agreement With WellSpring Pharma For Phenoxybenzamine Hydrochloride Capsules 17
Prasco Labs Enters into Distribution Agreement with Sunovion Pharma for Xopenex 18
ViroPharma Enters Into Co-Marketing Agreement With Prasco Labs For Vancocin 19
Prasco Labs Enters Into Co-Marketing Agreement With Shire For Carbatrol 20
Asset Transactions 21
IGI Labs Acquires Econazole Nitrate Cream From Prasco 21
Acquisition 22
Prasco Laboratories Acquires Additional stake in Aprecia Pharma 22
Prasco LLC – Key Competitors 23
Prasco LLC – Key Employees 24
Prasco LLC – Locations And Subsidiaries 25
Head Office 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Prasco LLC, Pharmaceuticals & Healthcare, Key Facts 2
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Prasco LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Prasco LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Prasco LLC, Medical Devices Deals, 2012 to YTD 2018 9
Prasco LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Prasco to Acquire Authorized Generic of Adderall XR Capsules from Teva Pharma and Shire 11
Prasco Lab Enters into Co-Marketing Agreement with Takeda Pharma 13
Prasco Labs Enters into Distribution Agreement with Recordati Rare Diseases 14
Prasco Labs Enters Into Distribution Agreement With Eli Lilly For Evista 15
Prasco Labs Enters Into Agreement With Shire For Distribution Of Fosrenol 16
Prasco Labs Enters Into Distribution Agreement With WellSpring Pharma For Phenoxybenzamine Hydrochloride Capsules 17
Prasco Labs Enters into Distribution Agreement with Sunovion Pharma for Xopenex 18
ViroPharma Enters Into Co-Marketing Agreement With Prasco Labs For Vancocin 19
Prasco Labs Enters Into Co-Marketing Agreement With Shire For Carbatrol 20
IGI Labs Acquires Econazole Nitrate Cream From Prasco 21
Prasco Laboratories Acquires Additional stake in Aprecia Pharma 22
Prasco LLC, Key Competitors 23
Prasco LLC, Key Employees 24

List of Figures
Prasco LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Prasco LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Prasco LLC, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Prasco LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Grupo Posadas Sab De Cv:企業の戦略・SWOT・財務分析
    Grupo Posadas Sab De Cv - Strategy, SWOT and Corporate Finance Report Summary Grupo Posadas Sab De Cv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Verizon Communications Inc.:企業の戦略・SWOT・財務情報
    Verizon Communications Inc. - Strategy, SWOT and Corporate Finance Report Summary Verizon Communications Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Materialise NV (MTLS):企業の財務・戦略的SWOT分析
    Materialise NV (MTLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • The Walt Disney Company:企業の戦略・SWOT・財務分析
    The Walt Disney Company - Strategy, SWOT and Corporate Finance Report Summary The Walt Disney Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • BASF SE:戦略・SWOT・企業財務分析
    BASF SE - Strategy, SWOT and Corporate Finance Report Summary BASF SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • North Eastern Electric Power Corporation Ltd:電力:M&Aディール及び事業提携情報
    Summary North Eastern Electric Power Corp Ltd (NEEPCO) is a government owned electric utility that generates, procures and sells electricity. The company designs, constructs, operates and maintains hydro, thermal and gas projects. NEEPCO generates electricity from hydro, thermal, and solar sources; …
  • Hindustan Petroleum Corporation Limited:企業の戦略・SWOT・財務情報
    Hindustan Petroleum Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Hindustan Petroleum Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Holidaybreak Ltd:企業の戦略・SWOT・財務情報
    Holidaybreak Ltd - Strategy, SWOT and Corporate Finance Report Summary Holidaybreak Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Volkswagen AG:戦略・SWOT・企業財務分析
    Volkswagen AG - Strategy, SWOT and Corporate Finance Report Summary Volkswagen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • SBS Transit Ltd.:戦略・SWOT・企業財務分析
    SBS Transit Ltd. - Strategy, SWOT and Corporate Finance Report Summary SBS Transit Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Exactech Inc (EXAC):企業の財務・戦略的SWOT分析
    Summary Exactech Inc (Exactech) is a medical device company that offers orthopedic implant devices and related surgical instruments. The company’s products comprise hip implants, shoulder implants, knee implants, extremity implants, biologics and spine, and other products. It also provides biologic …
  • Maruti Suzuki India Ltd (MARUTI):企業の財務・戦略的SWOT分析
    Maruti Suzuki India Ltd (MARUTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Polo Resources Ltd (POL):石油・ガス:M&Aディール及び事業提携情報
    Summary Polo Resources Ltd (Polo Resources) is a natural resource and mine development investment company that evaluates, acquires, and develops substantial investments in companies and projects. The company also invests in exploration companies. It invests in the gold, oil and gas, coal, phosphate, …
  • OncoMed Pharmaceuticals Inc (OMED):企業の財務・戦略的SWOT分析
    Summary OncoMed Pharmaceuticals Inc (OncoMed) is a clinical-stage biopharmaceutical company focused on discovery and development of novel immuno-oncology (IO) therapeutics for the treatment of cancers. Its pipeline product candidates include navicixizumab, rosmantuzumab, Gitrl-FC Trimer, and anti-TI …
  • Energy Development Corp (EDC):企業の財務・戦略的SWOT分析
    Energy Development Corp (EDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Yihai International Holding Ltd (1579):企業の財務・戦略的SWOT分析
    Yihai International Holding Ltd (1579) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Saudi Kayan Petrochemical Co (2350):企業の財務・戦略的SWOT分析
    Saudi Kayan Petrochemical Co (2350) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • ENN Energy Holdings Ltd (2688):企業の財務・戦略的SWOT分析
    ENN Energy Holdings Ltd (2688) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Kuwait Food Company (Americana) K.S.C.P. (FOOD):企業の財務・戦略的SWOT分析
    Kuwait Food Company (Americana) K.S.C.P. (FOOD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Oneida Ltd.:企業の戦略的SWOT分析
    Oneida Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆